Neumora Therapeutics Inc (NMRA)

04:55 AM

What risks investors should watch in Neumora Therapeutics Inc. stockEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com

04:55 AM

Nov 01, 2025

Is Neumora Therapeutics Inc. stock entering bullish territoryJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com

Nov 01, 2025

Nov 01, 2025

Will Neumora Therapeutics’ (NMRA) Novel Drug Pipeline Define Its Competitive Edge in Biotech? - simplywall.st

Nov 01, 2025

Nov 01, 2025

What momentum shifts mean for Neumora Therapeutics Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Regression analysis insights on Neumora Therapeutics Inc. performance2025 Year in Review & Daily Profit Maximizing Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Heatmap analysis for Neumora Therapeutics Inc. and competitors2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Why Neumora Therapeutics Inc. stock is a must watch in 2025July 2025 WrapUp & Low Volatility Stock Suggestions - newser.com

Oct 31, 2025

Oct 31, 2025

Neumora Therapeutics Inc. stock outlook for YEARJuly 2025 Review & Free Safe Capital Growth Stock Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 04:44:03 - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 03:53:08 - newser.com

Oct 31, 2025

Oct 31, 2025

How moving averages guide Neumora Therapeutics Inc. trading2025 Sector Review & Low Risk High Win Rate Picks - newser.com

Oct 31, 2025

Oct 31, 2025

Neumora Therapeutics (NMRA): Evaluating Valuation Following Dual Pipeline Advances in Psychiatry and Obesity - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Can a trend reversal in Neumora Therapeutics Inc. lead to recoveryExit Point & AI Driven Price Predictions - newser.com

Oct 31, 2025

Oct 30, 2025

Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating - Insider Monkey

Oct 30, 2025

Oct 30, 2025

Arch Venture Partners Xii, Llc Acquires 1,915,700 Shares of Neumora Therapeutics (NASDAQ:NMRA) Stock - MarketBeat

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics (NASDAQ:NMRA) Director Kristina Burow Acquires 1,915,700 Shares - MarketBeat

Oct 30, 2025

Oct 30, 2025

Is Neumora Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com

Oct 30, 2025

Oct 30, 2025

Neumora Therapeutics Stock (NMRA) Opinions on Obesity Drug Data Release - Quiver Quantitative

Oct 30, 2025

Oct 30, 2025

Guggenheim upgrades Neumora Therapeutics, Inc. (NMRA) to a Buy - The Globe and Mail

Oct 30, 2025

Oct 30, 2025

Neumora to initiate phase 1 study of oral obesity pill - MSN

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 01:21:45 - newser.com

Oct 30, 2025

Oct 29, 2025

Major Stakeholders Make Bold Moves in Neumora Therapeutics! - TipRanks

Oct 29, 2025

Oct 29, 2025

Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $8.00 - MarketBeat

Oct 29, 2025

Oct 29, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 29, 2025

Oct 29, 2025

Is Neumora Therapeutics Inc. stock a top pick in earnings season2025 Buyback Activity & Safe Entry Zone Tips - fcp.pa.gov.br

Oct 29, 2025

Oct 28, 2025

14 Stocks Under $5 with Highest Upside Potential - Insider Monkey

Oct 28, 2025

Oct 28, 2025

A Quick Look at Today's Ratings for Neumora Therapeutics(NMRA.US), With a Forecast Between $5 to $18 - 富途牛牛

Oct 28, 2025

Oct 28, 2025

Needham Maintains Neumora Therapeutics (NMRA) Buy Recommendation - Nasdaq

Oct 28, 2025

Oct 28, 2025

Why hedge funds are buying Neumora Therapeutics Inc. stock2025 Market Trends & Weekly Top Gainers Alerts - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

Real time social sentiment graph for Neumora Therapeutics Inc.2025 Top Gainers & Verified Entry Point Signals - newser.com

Oct 28, 2025

Oct 28, 2025

Published on: 2025-10-30 01:45:00 - newser.com

Oct 28, 2025

Oct 27, 2025

Will Neumora Therapeutics Inc. stock reach Wall Street targetsEarnings Recap Summary & Weekly Hot Stock Watchlists - fcp.pa.gov.br

Oct 27, 2025

Oct 27, 2025

Neumora initiates phase 1 study of second M4 PAM compound By Investing.com - Investing.com Philippines

Oct 27, 2025

Oct 27, 2025

How Neumora Therapeutics Inc. stock valuations compare to rivalsPortfolio Return Report & Free Safe Entry Trade Signal Reports - fcp.pa.gov.br

Oct 27, 2025

Oct 27, 2025

Neumora’s obesity drug shows up to 26% weight loss in preclinical studies - Investing.com Canada

Oct 27, 2025

Oct 27, 2025

Neumora Therapeutics’ Phase 3 Study on NMRA-335140: A Potential Breakthrough for Major Depressive Disorder - TipRanks

Oct 27, 2025

Oct 27, 2025

Neumora Therapeutics’ Phase 3 Study on NMRA-335140: A Potential Game-Changer for Depression Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Neumora initiates phase 1 study of second M4 PAM compound - Investing.com

Oct 27, 2025